Beyond Air (NASDAQ:XAIR) Issues Earnings Results, Beats Estimates By $0.09 EPS

Beyond Air (NASDAQ:XAIR) issued its quarterly earnings data on Monday. The company reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.09, Zacks reports. Beyond Air had a negative return on equity of 227.29% and a negative net margin of 2,369.17%. During the same quarter in the prior year, the company posted ($0.50) earnings per share.

Beyond Air Price Performance

Shares of XAIR opened at $0.44 on Tuesday. The company has a market cap of $33.28 million, a P/E ratio of -0.31 and a beta of -0.15. The stock has a fifty day moving average price of $0.42 and a 200 day moving average price of $0.44. The company has a debt-to-equity ratio of 0.37, a current ratio of 5.76 and a quick ratio of 5.38. Beyond Air has a 12 month low of $0.30 and a 12 month high of $2.17.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.